The University of Bristol and biopharmaceutical company, PhiloGene Inc announced today a deal, which could help further the development of a pioneering anti-cancer drug, thanks to two researchers from the University’s Department of Physiology and Pharmacology .
Get the full story...
Japan 's health authorities have approved Roche's cancer drug Herceptin for the treatment of HER2-positive breast cancer.
Get the full story...
Pharmaceutical companies make billions of dollars from top-selling drugs. But, the communities that harbor the traditional knowledge and genetic resources from which these drugs are made, reap few benefits. The World Intellectual Property Organization, which oversees patents, trademarks and copyrights, has been working for the past five years to reach an agreement that would help spread the wealth from products stemming from traditional resources.
Read the full story